Knight Therapeutics Announces Approval of Minjuvi® (tafasitamab) in Mexico
Knight Therapeutics MONTREAL, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Mexi...